<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01111747</url>
  </required_header>
  <id_info>
    <org_study_id>0162/08</org_study_id>
    <secondary_id>CaPPesqHCFMUSP 0162/2008</secondary_id>
    <nct_id>NCT01111747</nct_id>
  </id_info>
  <brief_title>Patellar Tendon Regeneration With Platelet-rich Plasma</brief_title>
  <official_title>Regeneration of the Patellar Tendon After Harvesting Its Central Third With Platelet-rich Plasma. Prospective and Randomized Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Ortopedia e Traumatologia - HCFMUSP - São Paulo, Brazil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The central third of the patellar tendon is used as a donor site for anterior cruciate
      ligament (ACL) reconstruction. After months or years the harvest site partially regenerates.
      The regeneration process is accomplished by biological mechanisms,including cells and
      proteins known as growth factors. The platelets are natural reservoirs of growth factors, and
      a platelet concentrate known as Platelet-Rich Plasma (PRP) has a three to five fold increase
      in growth factors. The hypothesis of the study is that the PRP can improve the regeneration
      of the patellar tendon.

      The platelets are obtained from the patient's blood through a filtration system called
      apheresis, with the use of 250 milliliters of blood, with a sterile system. All the others
      components of blood (red cells, plasma, white cells) returns to the patient. The PRP is then
      applied in the harvest site on the patellar tendon, at the end of ACL reconstruction.

      The patients are randomized in two groups, one with the use of PRP and the other group
      without PRP. This information for the patients will be granted just at the end of the
      research. After the surgery the rehabilitation protocol is the same for both groups. An
      isokinetic testing is done before the surgery and after six months. Questionnaires about the
      knee function are asked before the surgery and after six months. A magnetic resonance imaging
      is performed after six months to evaluate the tendon regeneration.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the patellar tendon regeneration with magnetic resonance imaging.</measure>
    <time_frame>Six months</time_frame>
    <description>Six months after the surgery a magnetic resonance imaging will be done to evaluate the regeneration of the patellar tendon donor site. The area of the gap, related to the tendon harvest, will be measured and compared between the groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Isokinetic testing and questionaires.</measure>
    <time_frame>Six months</time_frame>
    <description>Six months after the surgery, patients will answer to questionaires about their knee function and do an isokinetic testing to evaluate their muscle strength. The results will be compared between the groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Knee Instability</condition>
  <arm_group>
    <arm_group_label>PRP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this group PRP will be used in the patellar tendon donor site.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>In this group PRP will not be aded to the patellar tendon donor site</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet-rich plasma</intervention_name>
    <description>Intra-operative use of platelet-rich plasma in the patellar tendon after harvesting its central third for ACL reconstruction.</description>
    <arm_group_label>PRP</arm_group_label>
    <other_name>PRP</other_name>
    <other_name>platelet gel</other_name>
    <other_name>platelet concentrate</other_name>
    <other_name>growth factors concentrate</other_name>
    <other_name>plasma rich in growth factors</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Control group</intervention_name>
    <description>In this group PRP will not be added to the patellar tendon donor site at the end of ACL reconstruction.</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>PRP</other_name>
    <other_name>platelet-rich plasma</other_name>
    <other_name>platelet gel</other_name>
    <other_name>platelet concentrate</other_name>
    <other_name>growth factors concentrate</other_name>
    <other_name>plasma rich in growth factors</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  indication of anterior cruciate ligament surgery with patellar ligament

          -  skeletal maturity

        Exclusion Criteria:

          -  other knee ligament injuries

          -  severe chondral lesions

          -  osteoarthritis

          -  non-compliance to the rehabilitation

          -  previous surgery in the affected knee

          -  reoperation during the time of the study for an unrelated condition

          -  infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adriano M Almeida, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Ortopedia e Traumatologia - HCFMUSP - São Paulo, Brazil</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arnaldo J Hernandez, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Instituto de Ortopedia e Traumatologia - HCFMUSP - São Paulo, Brazil</affiliation>
  </overall_official>
  <reference>
    <citation>Kartus J, Movin T, Papadogiannakis N, Christensen LR, Lindahl S, Karlsson J. A radiographic and histologic evaluation of the patellar tendon after harvesting its central third. Am J Sports Med. 2000 Mar-Apr;28(2):218-26.</citation>
    <PMID>10750999</PMID>
  </reference>
  <reference>
    <citation>Meisterling RC, Wadsworth T, Ardill R, Griffiths H, Lane-Larsen CL. Morphologic changes in the human patellar tendon after bone-tendon-bone anterior cruciate ligament reconstruction. Clin Orthop Relat Res. 1993 Apr;(289):208-12.</citation>
    <PMID>8472418</PMID>
  </reference>
  <reference>
    <citation>Svensson M, Kartus J, Ejerhed L, Lindahl S, Karlsson J. Does the patellar tendon normalize after harvesting its central third?: a prospective long-term MRI study. Am J Sports Med. 2004 Jan-Feb;32(1):34-8.</citation>
    <PMID>14754721</PMID>
  </reference>
  <reference>
    <citation>Anaguchi Y, Yasuda K, Majima T, Tohyama H, Minami A, Hayashi K. The effect of transforming growth factor-beta on mechanical properties of the fibrous tissue regenerated in the patellar tendon after resecting the central portion. Clin Biomech (Bristol, Avon). 2005 Nov;20(9):959-65.</citation>
    <PMID>16055249</PMID>
  </reference>
  <reference>
    <citation>Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004 Jan;91(1):4-15. Review.</citation>
    <PMID>14691563</PMID>
  </reference>
  <reference>
    <citation>Spindler KP, Nanney LB, Davidson JM. Proliferative responses to platelet-derived growth factor in young and old rat patellar tendon. Connect Tissue Res. 1995;31(2):171-7.</citation>
    <PMID>15612333</PMID>
  </reference>
  <reference>
    <citation>Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med. 2003;33(5):381-94. Review.</citation>
    <PMID>12696985</PMID>
  </reference>
  <reference>
    <citation>Aspenberg P. Stimulation of tendon repair: mechanical loading, GDFs and platelets. A mini-review. Int Orthop. 2007 Dec;31(6):783-9. Epub 2007 Jun 22.</citation>
    <PMID>17583812</PMID>
  </reference>
  <reference>
    <citation>Rodeo SA, Potter HG, Kawamura S, Turner AS, Kim HJ, Atkinson BL. Biologic augmentation of rotator cuff tendon-healing with use of a mixture of osteoinductive growth factors. J Bone Joint Surg Am. 2007 Nov;89(11):2485-97.</citation>
    <PMID>17974893</PMID>
  </reference>
  <reference>
    <citation>Sánchez M, Anitua E, Azofra J, Andía I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med. 2007 Feb;35(2):245-51. Epub 2006 Nov 12.</citation>
    <PMID>17099241</PMID>
  </reference>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2010</study_first_submitted>
  <study_first_submitted_qc>April 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 28, 2010</study_first_posted>
  <last_update_submitted>March 13, 2012</last_update_submitted>
  <last_update_submitted_qc>March 13, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>platelet-rich plasma</keyword>
  <keyword>patellar ligament</keyword>
  <keyword>regeneration</keyword>
  <keyword>growth substances</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitogens</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

